Resource Listings

This article outlines five key considerations for in-house counsel looking to cost-effectively enforce trademark rights in Canada.

This article explains the top ten amendments to the United States Mexico Canada Agreement (USMCA) that were made after the 2018 American midterm elections. These new amendments affect Canadian IP law .

In this ACC Guide, an overview of recent developments in post-grant proceedings before the United States Patent Trial and Appeal Board are explained. With relatively new administrative proceedings developed for challenging competitor grants, in-house counsel will need to familiarize themselves with this knowledge to prepare for hearings.

Digital identities are a set of attributes that can allow an individual to be represented in a digital form in a online environment. In this article, in-house counsel will learn the basics of how digital identities interact and why they're so important in a global environment. This resource was published in March 2019.

This article discusses the highlights of reform to the Hong Kong patent system.

This article explores Hong Kong brand trademark laws, including parallel imports, the exhaustion principle, and use of copyright law.

As social media has taken an increasingly central role in building brands and promoting businesses, in-house counsel need to keep related legal issues top-of-mind. In this Top Ten, learn how to navigate the non-stop world of social media marketing.

Patented medicine regulations in Canada can be complex and the review process is fast-paced. In this Top Ten, in-house counsel will learn the essential points of how to prepare for the "Regulations" review. Editor's note: This article was updated to reflect recent developments; a prior version of this article was published on August 6, 2020.

Checklist, US

This is a copyright assignment agreement.

This ACC Guide provides an overview on trade secrets in the United States. It will explain the legal framework that in-house counsel can use to inform, protect, and provide guidance when dealing with trade secrets, intellectual property usage, and what you company might face in attempting to protect certain information.

In this Sample Exit Interview Form, a United States Company is categorizing access to tools and information from the former employee.

In this example of possible "Notice" language about Whistleblower Immunity, language is constructed to inform a possible whistleblower of their rights and immunity.

In this Sample Acknowledgement Form, an incoming employee is reviewing and acknowledging the trade secrets policy the hiring company has instituted.

In this Sample Trade Secret Policy, in-house counsel can review informative language about trade secrets and how to define them for potential new employees in the United States.

Canada is an attractive market for pharmaceutical manufacturers. Most Canadian consumers have some form of drug coverage through government programs and/or private insurance. Below are ten patent and regulatory topics that in-house counsel need to know before bringing an innovative product to Canada. Editor's note: This article was updated to reflect recent developments; a prior version of this article was published on December 16, 2020.

In September 2017, amendments to the Patented Medicines (Notice of Compliance) Regulations introduced a new scheme for pharmaceutical patent linkage litigation in Canada. That scheme is now much closer to the United States' (US) Hatch-Waxman scheme, but with remaining key differences that are explained in this article.

Amendments to the Canadian Patent Act and enactment of the Certificate of Supplementary Protection Regulations flowing from the Canada-European Union (EU) Comprehensive Economic and Trade Agreement (CETA) in September 2017 introduced a new framework in Canada for the issuance of Certificates of Supplementary Protections (CSPs). Key aspects of the two regimes, Canada's and the EU's, are compared in this chart.

Understand the implications of the Brexit agreement of December 24, 2020 between the United Kingdom and the European Union.